Peptide Vials (SS31, 10 mg each): 8 weeks (Standard: 510 mg/day) 50 vials 12 weeks (Standard maintenance at 10 mg/day) 77 vials 12 weeks (Advanced: escalating to 15 mg/day) 105 vials Insulin Syringes (U100, 1 mL capacity): Per week (standard dosing): 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes Advanced protocols with split injections may require 2 syringes per day for higher doses Bacteriostatic Water (30 mL bottles): Use 1.0 mL per vial for reconstitution
The findings derive from laboratory research and do not describe or imply any effect, benefit, or use in humans or animals
209,210 Shank3 -knockout mice showed a decrease in the number of corticostriatal connections, 202,211 whereas defects in NMDAR-dependent excitatory neurotransmission and synaptic plasticity have been observed in Shank2 -knockout mice
Supplied as a powder for laboratory investigations into NAD+-related metabolism, methylation pathway markers, and energy-regulation mechanisms in controlled experimental models
This is desirable for wound healing but theoretically problematic for patients with active malignancies or a history of angiogenesis-dependent tumors
